Core Insights - The article discusses the potential of investing in microcap or small-cap stocks trading under $10, emphasizing the importance of screening for companies with significant business improvements such as revenue and earnings growth [1] Group 1: Investment Criteria - Stocks should trade between $5 to $10 and have at least a Buy rating from analysts [1] - Companies must show a minimum of 10% earnings growth in the latest full year and consistent positive revenue growth over the last three years [1] Group 2: Company Highlights - Materialise NV (MTLS): - The company reported a 10.4% year-over-year revenue increase for 2023, with its medical segment surpassing 100 million euros in revenue [3] - EBITDA increased by 65%, and the company turned a loss of 0.04 euro cent into a profit of 0.11 euro [3] - Analysts rate it as a Strong Buy with a 134% upside potential based on high target prices [3] - Ardelyx (ARDX): - The company specializes in advanced medicine for unmet medical needs, with significant revenue growth driven by its product IBSRELA, which saw sales rise from $15.6 million to $80 million [4][5] - Total revenue reached $124.5 million, and the company reported a net loss of 30 cents per share, an improvement from 42 cents the previous year [5] - Current stock price is around $6 to $7, with a Strong Buy rating and a high target price of $15 [5] - Sera Prognostics (SERA): - The company focuses on women's health diagnostics, reporting revenue growth from $268,000 to $306,000 in 2023 [7] - The bottom line improved from a loss of $1.43 in 2022 to a loss of $1.16 in 2023 [7] - Analysts continue to rate the stock as a Strong Buy, anticipating increased product demand [7]
3 Stocks Under $10 With the Potential to Make You a Millionaire